Changes in Intracellular Ca2+ Mobilization and Ca2+ Sensitization as Mechanisms of Action of Physiological Interventions and Inotropic Agents in Intact Myocardial Cells.
スポンサーリンク
概要
- 論文の詳細を見る
Physiological and pharmacological interventions are used to regulate cardiac contractile functions via modulation of Ca2+ signaling. The relevant regulatory mechanisms have recently been assessed in detail by use of novel experimental procedures, which include simultaneous measurements of intracellular levels of Ca2+ ions and contractile force in intact myocardial preparations loaded with the intracellular Ca2+ indicator aequorin and fluorescent dyes, namely, fura-2, indo-1 and fluo-3. Association with or dissociation from intracellular Ca2+ transients of contractile activity is taken as evidence that reflects the primary mechanism of action of individual inotropic interventions. In addition, motility assays of actin-myosin interactions in vitro have made it possible to define the site of action of Ca2+ sensitizers as troponin C and the interaction of the troponin-tropomyosin complex with actin or the actin-myosin interface at crossbridges. Frank-Starling mechanism operates at the level of the binding of Ca2+ ions to troponin C and subsequent regulatory processes, while the forcefrequency relationship is mainly ascribed to an alteration in the intracellular mobilization of Ca2+ ions. Cardiotonic agents can be classified as follows: 1) agents that act via a cyclic AMP-dependent or a cyclic AMP-independent mechanism; and 2) agents that facilitate the intracellular mobilization of Ca2+ ions or increase in myofibrillar sensitivity to Ca2+ ions. Regulatory mechanisms mediated via the phosphorylation of functional proteins induced by cyclic AMP, which is responsible for the actions of novel cardiotonic agents, β1-adrenoceptor partial agonist and selective inhibitors of phosphodiesterase (PDE) III, have currently been clarified in more detail. Ca2+ sensitizers are of extreme therapeutic interest because of their ability to increase myocardial contractility without an increase in activation energy; they are devoid of risks of arrhythmogenicity and myocardial cell death from intracellular Ca2+ overload; and they effectively reverse contractile dysfunction under pathophysiological situations, such as acidosis or myocardial stunning.
- International Heart Journal刊行会の論文
著者
関連論文
- Receptor Subtypes Mediating the Inotropic Effects and Ca2+ Signaling Induced by Endothelin-1 Through Crosstalk With Norepinephrine in Canine Ventricular Myocardium
- Cardiac-specific Overexpression of Diacylglycerol Kinase ζ Prevents Angiotensin II-induced Cardiac Hypertrophy in Transgenic Mice(Cardiac Hypertrophy 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Cardiac Ca^ Signaling and Ca^ Sensitizers
- The G-Protein G_0 in Mammalian Cardiac Muscle: Localization and Coupling to A_1 Adenosine Receptors
- The State of Cardiac Contractile Proteins during the Diastolic Phase : SYMPOSIUM ON HEART MECHANICS IN DIASTOLE
- Receptor Subtypes Mediating the Inotropic Effects and Ca^ Signaling Induced by Endothelin-1 Through Crosstalk With Norepinephrine in Canine Ventricular Myocardium
- Wortmannin Inhibits the Increase in Myofilament Ca^ Sensitivity Induced by Cross-Talk of Endothelin-1 With Norepinephrine in Canine Ventricular Myocardium
- Differential Inotropic Effects of Endothelin-1, Angiotensin II, and Phenylephrine Induced by Crosstalk With cAMP-Mediated Signaling Process in Dog Ventricular Myocardium
- FAILURE OF DIBUTYRYL AND 8-BROMO-CYCLIC GMP TO MIMIC THE ANTAGONISTIC ACTION OF CARBACHOL ON THE POSITIVE INOTROPIC EFFECTS OF SYMPATHOMIMETIC AMINES IN THE CANINE ISOLATED VENTRICULAR MYOCARDIUM
- EFFECT OF MANGANESE IONS ON THE CONTRACTION AND AUTOMATICITY OF THE BLOOD-PERFUSED CANINE PAPILLARY MUSCLE
- INHIBITION OF THE POSITIVE INOTROPIC EFFECT OF DOPAMINE BY YM-09538 WITH α- AND β-ADRENOCEPTOR ANTAGONISTIC ACTION IN THE RABBIT PAPILLARY MUSCLE
- ADRENOCEPTORS MEDIATING THE POSITIVE INOTROPIC EFFECT IN THE CANINE ATRIAL MYOCARDIUM
- CORRELATION OF CYCLIC AMP AND CYCLIC GMP LEVELS WITH CHANGES IN CONTRACTILE FORCE OF DOG VENTRICULAR MYOCARDIUM DURING CHOLINERGIC ANTAGONISM OF POSITIVE INOTROPIC ACTIONS OF HISTAMINE, GLUCAGON, THEOPHYLLINE AND PAPAVERINE
- Pharmacological Characteristics of Inhibitory Action of the Selective α_1-Antagonist JTH-601 on the Positive Inotropic Effect Mediated by α_1-Adrenoceptors in Isolated Rabbit Papillary Muscle
- INTRACELLULAR CALCIUM MOBILIZATION AND ITS MODULATION BY PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL INTERVENTIONS IN AEQUORIN-INJECTED MYOCARDIAL CELLS
- Physiological and Pathophysiological Modulation of Calcium Signaling in Myocardial Cells : 54th Annual Scientific Session of the Japanese Circulation Society
- SUBCELLULAR MECHANISMS UNDERLYING THE INHIBITORY ACTION OF MUSCARINIC CHOLINERGIC RECEPTOR AGONISTS ON MAMMALIAN MYOCARDIAL CONTRACTILITY IN RELATION TO CHANGES IN INTRACELLULAR CALCIUM TRANSIENTS
- (-)-Enantiomer EMD 57439 Antagonizes the Ca^ Sensitizing Effect of (+)-Enantiomer EMD 57033 on Diastolic Function but Not on Systolic Function in Rabbit Ventricular Cardiomyocytes
- Differential effects of isoproterenol on the canine atrial action potential in the presence of carbachol or nicorandil.
- Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
- Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo(1,2-a)pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
- Inotropic Effects of Staurosporine, NA 0345 and H-7, Protein Kinase C Inhibitors, on Rabbit Ventricular Myocardium: Selective Inhibition of the Positive Inotropic Effect Mediated by .ALPHA.1-Adrenoceptors.
- The Na+-Ca2+ Exchanger Contributes to .BETA.-adrenoceptor Mediated Positive Inotropy in Mouse Heart.
- Changes in Intracellular Ca2+ Mobilization and Ca2+ Sensitization as Mechanisms of Action of Physiological Interventions and Inotropic Agents in Intact Myocardial Cells.